Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.36 is 48% above its 2-year average of -2.62, near the high end of its 2-year range (-4.25–-1.36).
24.86% above its 12-month average of -1.81.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.39.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 7 comparable quarters.
EARNINGS PER SHARE (EPS)
-1.36
EARNINGS PER SHARE (EPS) AVG TTM
-1.81
EARNINGS PER SHARE (EPS) AVG 3Y
N/A
EARNINGS PER SHARE (EPS) AVG 5Y
N/A
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+24.86%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Carlsmed, Inc.
Market Cap
$397.99M
Earnings Per Share (EPS)
-1.36
TTM Avg
-1.81
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$396.93M
Earnings Per Share (EPS)
-1.71
TTM Avg
-1.36
3Y Avg
-1.12
5Y Avg
-1.12
Market Cap
$402.17M
Earnings Per Share (EPS)
-5.51
TTM Avg
-4.26
3Y Avg
-3.91
5Y Avg
-2.87
Market Cap
$404.24M
Earnings Per Share (EPS)
-1.19
TTM Avg
-2.69
3Y Avg
-2.49
5Y Avg
-2.21
Market Cap
$405.74M
Earnings Per Share (EPS)
-2.08
TTM Avg
-1.97
3Y Avg
-1.74
5Y Avg
-0.94
Market Cap
$406.58M
Earnings Per Share (EPS)
-4.63
TTM Avg
-6.16
3Y Avg
-6.16
5Y Avg
-6.16
Market Cap
$385.15M
Earnings Per Share (EPS)
-3.79
TTM Avg
-4.17
3Y Avg
-5.22
5Y Avg
-3.47
Market Cap
$411.00M
Earnings Per Share (EPS)
0.50
TTM Avg
0.08
3Y Avg
-0.25
5Y Avg
-0.31
Market Cap
$411.21M
Earnings Per Share (EPS)
-5.18
TTM Avg
-2.77
3Y Avg
-1.90
5Y Avg
-1.90
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Carlsmed, Inc. (CARL) | $397.99M | -1.36 | -1.81 | N/A | N/A |
| Shoulder Innovations, Inc. (SI)vs › | $396.93M | -1.71 | -1.36 | -1.12 | -1.12 |
| Neurogene Inc. (NGNE)vs › | $402.17M | -5.51 | -4.26 | -3.91 | -2.87 |
| Myriad Genetics, Inc. (MYGN)vs › | $404.24M | -1.19 | -2.69 | -2.49 | -2.21 |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $405.74M | -2.08 | -1.97 | -1.74 | -0.94 |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $406.58M | -4.63 | -6.16 | -6.16 | -6.16 |
| REGENXBIO Inc. (RGNX)vs › | $385.15M | -3.79 | -4.17 | -5.22 | -3.47 |
| Strata Critical Medical, Inc. (SRTA)vs › | $411.00M | 0.50 | 0.08 | -0.25 | -0.31 |
| MapLight Therapeutics, Inc. (MPLT)vs › | $411.21M | -5.18 | -2.77 | -1.90 | -1.90 |
| Orthofix Medical Inc. (OFIX)vs › | $380.37M | -1.54 | -2.79 | -2.67 | -2.08 |
Trailing EPS (TTM)
$-1.36
Forward EPS (Est.)
$-1.45
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -2.12 |
| 2024-12-31 | -1.50 |
| 2023-12-31 | -4.25 |
